Redox control of CD8 T cell proliferation, differentiation and death
氧化还原控制 CD8 T 细胞增殖、分化和死亡
基本信息
- 批准号:8240546
- 负责人:
- 金额:$ 32.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-04-01 至 2015-03-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsAddressAdoptive TransferAntigensAntioxidantsAreaAutoimmunityBiochemicalBiologicalBiological AssayBiotinBone MarrowCD8B1 geneCalciumCell Differentiation processCellsCessation of lifeCu-Superoxide DismutaseCysteineCytolysisDataDendritic CellsExperimental DesignsFundingGenesGoalsHealthImmunologyIn VitroInfectionJournalsKnockout MiceLabelLiteratureLymphocytic choriomeningitis virusMass Spectrum AnalysisModificationMolecularMonitorMusOrgan TransplantationOxidation-ReductionPTPN11 genePTPN6 genePaperPeptidesProliferatingProtein Tyrosine PhosphataseProteinsPublished CommentReadabilityReagentReportingRoleSignal TransductionSignaling ProteinSiteStimulusSulfenic AcidsSystemT-Cell ActivationT-Cell ProliferationT-LymphocyteTechnologyTestingTextTimeToxic effectTransgenesTransgenic MiceTransgenic OrganismsTumor Necrosis Factor-alphaTyrosine PhosphorylationVaccinationVirus DiseasesWorkcancer therapycatalasecell typedimedonehuman TNF proteinin vivonoveloverexpressionperoxiredoxin 2reactive oxygen intermediateresearch study
项目摘要
DESCRIPTION (provided by applicant): Our goal is to determine the molecular mechanisms by which reactive oxygen intermediates (ROI) control the activation, proliferation and differentiation of naive CD8+ T cells. During naive CD8+ T cell activation there is a rapid increase in tyrosine phosphorylation and calcium influx. At the same time there is also an increase in ROI. This increase in ROI is thought to be critical to normal T cell activation as co-incubation with anti-oxidants decreases the expansion of CD8+ T cells in vitro and in vivo during viral infection. The specific hypothesis that is being addressed in this proposal is that naive CD8+ T cell activation, proliferation and differentiation are controlled by ROI through the controlled modification of cysteines in signaling proteins to sulfenic acid. Specific Aim 1 will test the effects of modulating ROI on naive CD8+ T cell activation, proliferation and differentiation. P14 TCR transgenic mice that overexpress both catalase and Cu superoxide dismutase (CAT/SOD) or lack peroxiredoxin II (Prx II -/-) will be used. Purified naive CD8+ T cells from these mice will be activated in vitro by polyclonal stimuli or after interaction with peptide coated bone marrow derived dendritic cells. The in vivo effects of ROI modulation on CD8+ T cell activation, proliferation and differentiation will be determined by adoptive transfer into naive recipients followed by LCMV infection. In Specific Aim 2 we will determine the sulfenic acid modification of the protein tyrosine phosphatases SHP-1 and SHP-2 during CD8+ T cell activation, proliferation and differentiation. This will be accomplished through the use of our novel labeling reagents which allow the isolation and identification of sulfenic acid containing proteins. In the first part of Specific Aim 2, we will determine the modification of these PTPs in purified naive CD8+ T cells activated by polyclonal stimuli. In the second part of aim 2, we will determine how PTPs are modified in T cells activated by peptide coated dendritic cells.
PUBLIC HEALTH RELEVANCE: Understanding how CD8+ T cells become activated, proliferate and differentiate is critical to developing treatments to increase the number of antigen-specific cells during vaccination or cancer therapy and it is also important to reducing unneeded cells during organ transplant or autoimmunity.
描述(由申请人提供):我们的目标是确定活性氧中间体(ROI)控制初始CD8+ T细胞活化、增殖和分化的分子机制。在初始CD8+ T细胞活化过程中,酪氨酸磷酸化和钙内流迅速增加。与此同时,投资回报率也有所提高。这种ROI的增加被认为对正常T细胞激活至关重要,因为在病毒感染期间,与抗氧化剂共孵育可减少体内和体外CD8+ T细胞的扩增。该提案提出的具体假设是,幼稚CD8+ T细胞的激活、增殖和分化是由ROI通过对信号蛋白中半胱氨酸的控制修饰来控制的。特异性靶1将测试ROI调节对初始CD8+ T细胞活化、增殖和分化的影响。将使用过表达过氧化氢酶和铜超氧化物歧化酶(CAT/SOD)或缺乏过氧化物还毒素II (Prx II -/-)的P14 TCR转基因小鼠。来自这些小鼠的纯化的幼稚CD8+ T细胞将通过多克隆刺激或与肽包被的骨髓源树突状细胞相互作用被体外激活。在体内,ROI调节对CD8+ T细胞活化、增殖和分化的影响将通过过继转移到初始受体,然后感染LCMV来确定。在特异性目标2中,我们将确定在CD8+ T细胞活化、增殖和分化过程中,巯基酸修饰蛋白酪氨酸磷酸酶SHP-1和SHP-2。这将通过使用我们的新型标记试剂来完成,该试剂允许分离和鉴定含亚磺酸的蛋白质。在Specific Aim 2的第一部分中,我们将确定这些PTPs在多克隆刺激激活的纯化初始CD8+ T细胞中的修饰。在目标2的第二部分,我们将确定ptp是如何在被肽包被的树突状细胞激活的T细胞中被修饰的。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Increased CD8+ T-cell function following castration and immunization is countered by parallel expansion of regulatory T cells.
- DOI:10.1158/0008-5472.can-11-2499
- 发表时间:2012-04-15
- 期刊:
- 影响因子:11.2
- 作者:Tang S;Moore ML;Grayson JM;Dubey P
- 通讯作者:Dubey P
Au-ACRAMTU-PEt3 Alters Redox Balance To Inhibit T Cell Proliferation and Function.
- DOI:10.4049/jimmunol.1400391
- 发表时间:2015-09-01
- 期刊:
- 影响因子:0
- 作者:Langston PK;Yang M;Bierbach U;Parsonage D;Poole LB;Price MJ;Grayson JM
- 通讯作者:Grayson JM
Defects in apoptosis increase memory CD8+ T cells following infection of Bim-/-Faslpr/lpr mice.
Bim-/-Faslpr/lpr 小鼠感染后,凋亡缺陷会增加记忆 CD8 T 细胞。
- DOI:10.1016/j.cellimm.2011.07.003
- 发表时间:2011
- 期刊:
- 影响因子:4.3
- 作者:Weant,AshleyE;Michalek,RyanD;Crump,KatieE;Liu,Chun;Konopitski,AndrewP;Grayson,JasonM
- 通讯作者:Grayson,JasonM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JASON Mitchell GRAYSON其他文献
JASON Mitchell GRAYSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JASON Mitchell GRAYSON', 18)}}的其他基金
Repurposed Drugs to Inhibit Human T Cells and Autoimmunity
重新利用药物抑制人类 T 细胞和自身免疫
- 批准号:
8889627 - 财政年份:2014
- 资助金额:
$ 32.64万 - 项目类别:
Repurposed Drugs to Inhibit Human T Cells and Autoimmunity
重新利用药物抑制人类 T 细胞和自身免疫
- 批准号:
8771735 - 财政年份:2014
- 资助金额:
$ 32.64万 - 项目类别:
Interferon Alpha Regulation of Murine Gammaherpesvirus Latency
干扰素α对鼠丙型疱疹病毒潜伏期的调节
- 批准号:
8648978 - 财政年份:2011
- 资助金额:
$ 32.64万 - 项目类别:
Mechanisms of CD8+ T Cell Apoptosis During Acute and Chronic Viral Infections
急慢性病毒感染过程中CD8 T细胞凋亡机制
- 批准号:
8018876 - 财政年份:2010
- 资助金额:
$ 32.64万 - 项目类别:
Redox control of CD8 T cell proliferation, differentiation and death
氧化还原控制 CD8 T 细胞增殖、分化和死亡
- 批准号:
7556319 - 财政年份:2008
- 资助金额:
$ 32.64万 - 项目类别:
Redox control of CD8 T cell proliferation, differentiation and death
氧化还原控制 CD8 T 细胞增殖、分化和死亡
- 批准号:
7783793 - 财政年份:2008
- 资助金额:
$ 32.64万 - 项目类别:
Redox control of CD8 T cell proliferation, differentiation and death
氧化还原控制 CD8 T 细胞增殖、分化和死亡
- 批准号:
7464853 - 财政年份:2008
- 资助金额:
$ 32.64万 - 项目类别:
Redox control of CD8 T cell proliferation, differentiation and death
氧化还原控制 CD8 T 细胞增殖、分化和死亡
- 批准号:
8034740 - 财政年份:2008
- 资助金额:
$ 32.64万 - 项目类别:
GENE EXPRESSION IN ANTIGEN SPECIFIC LYMPHOCYTES DURING V
V 期间抗原特异性淋巴细胞的基因表达
- 批准号:
6372894 - 财政年份:2001
- 资助金额:
$ 32.64万 - 项目类别:
GENE EXPRESSION IN ANTIGEN SPECIFIC LYMPHOCYTES DURING V
V 期间抗原特异性淋巴细胞的基因表达
- 批准号:
6169102 - 财政年份:2000
- 资助金额:
$ 32.64万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 32.64万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 32.64万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 32.64万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 32.64万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 32.64万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 32.64万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 32.64万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 32.64万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 32.64万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 32.64万 - 项目类别:
Research Grant